http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112018015878-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2017-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9029169d83b592776085fb7c882643f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac0b50ca712738bb5f4eb2e80bfd3aae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f820329d3d2d8a9c93363e40f1acd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4f31d345084ad7b9453b997b54e992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f05ecbb771f5fabfeca8da074d70db1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04c8bd032a599b12644546813f35da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6b9db78e9f55bfdaa84b138b6fdbb9
publicationDate 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112018015878-A2
titleOfInvention A trifluoroacetic acid salt of a TLR7 agonist, a crystal form B, a preparation method and a use thereof
abstract the present invention relates to the trifluoracetate salt of a tlr7 2-butoxy-7- (4- (pyrrolidin-1-ylmethyl) -benzyl) -5h-pyrrol [3,2-d] pyrimidin-4-amine agonist (formula i), crystalline form b of the trifluoracetate salt, methods for preparing the trifluoracetate salt and crystalline form b and uses of the trifluoracetate salt and crystalline form b.
priorityDate 2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574059

Total number of triples: 26.